Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;70(11):2196-2204.
doi: 10.1136/gutjnl-2020-323931. Epub 2021 Sep 8.

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

Affiliations
Review

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

Annieke C G van Baar et al. Gut. 2021 Nov.
No abstract available

Keywords: diabetes mellitus; duodenal mucosa; fatty liver; gastrointestinal endoscopy; glucose metabolism.

PubMed Disclaimer

Conflict of interest statement

Competing interests: MN is in the Scientific Advisory Board of Caelus Pharmaceuticals, The Netherlands, and Kaleido Biosciences, USA. None of these is directly relevant to the current paper. DH has received honoraria from Fractyl for participating in scientific advisory boards. There are no patents, products in development or marketed products to declare. The other authors declare no competing financial interests.

Figures

Figure 1
Figure 1
Complex metabolic changes induced by bariatric surgery and interventions involving the duodenum. Inspiration for this figure came from Madsbad et al. FGF-19, fibroblast growth factor 19.
Figure 2
Figure 2
Illustrations with corresponding endoscopic views during the duodenal mucosal resurfacing (DMR) procedure: (A and B) introduction of the DMR catheter into the postpapillary duodenum; (C) submucosal lift and mucosal ablation; (D) postablation endoscopic view; (E and F) circumferentially ablated duodenal mucosa. Illustrations provided by Fractyl Laboratories.
Figure 3
Figure 3
Proposed algorithm of where duodenal mucosal remodelling might fit in the current management of T2D. DPP-4i, dipeptidyl peptidase-4 inhibitor; GLP-1RA, glucagon-like peptide-1 receptor agonist; HbA1c, haemoglobin A1c; SGLT2i, sodium-glucose cotransporter 2 inhibitor; SU, sulfonylurea derivative; T2D, type 2 diabetes.

References

    1. Gudbjörnsdottir S, Cederholm J, Nilsson PM, et al. . The National diabetes register in Sweden: an implementation of the St. Vincent Declaration for quality improvement in diabetes care. Diabetes Care 2003;26:1270–6. 10.2337/diacare.26.4.1270 - DOI - PubMed
    1. NHS Digital . National diabetes audit programme, 2021. Available: https://digital.nhs.uk/data-and-information/clinical-audits-and-registri...
    1. American Diabetes Association . 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. Diabetes Care 2021;44:S73–84. 10.2337/dc21-S006 - DOI - PubMed
    1. Mai K, Brachs M, Leupelt V, et al. . Effects of a combined dietary, exercise and behavioral intervention and sympathetic system on body weight maintenance after intended weight loss: results of a randomized controlled trial. Metabolism 2018;83:60–7. 10.1016/j.metabol.2018.01.003 - DOI - PubMed
    1. Look AHEAD Research Group . Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity 2014;22:5–13. 10.1002/oby.20662 - DOI - PMC - PubMed

Publication types

Substances